-SEC Filing
Morgan Stanley Maintains Overweight on ArcBest, Lowers Price Target to $138
Morgan Stanley analyst Ravi Shanker maintains ArcBest (NASDAQ:ARCB) with a Overweight and lowers the price target from $139 to $138.
Related Posts
Great Psychedelics And Business Events Are Coming In Q4: Check Them Out Here
The season for psychedelics conferences is right around the corner. From very large and well-known events to small meets, this year’s remaining months are loaded with on-site and virtual discussions around the natural plant and synthetic medicines revolutionizing mental health.
Hour Loop Q3 EPS $(0.0004) Up From $0.01 YoY, Sales $29.15M Up From $17.56M YoY
Third Quarter 2023 Financial ResultsNet revenues in the third quarter of 2023 were $29.2 million, compared to $17.6 million in the year-ago period. The increase was primarily due to continued growth and maturity in our
Dover Fueling Solutions Supplies LIQAL BTU System To LC3 Trasporti In Italy
Dover Fueling Solutions ("DFS"), a part of Dover (NYSE:DOV) and a leading global provider of advanced customer-focused technologies, services and solutions in the fuel and convenience retail industries, today